Diet High in Good Fats Just as Beneficial to Persons With Diabetes
CINCINNATIA new study by researchers at the University of Cincinnati (UC) finds that a low-carbohydrate, high-monounsaturated fat diet was just as beneficial for persons with type 2 diabetes as the traditional low-fat, high-carbohydrate diet.
The most important aspect of this research is that there are alternatives to the conventional low-fat, high-carb diet, says the studys principal investigator, Bonnie Brehm, PhD.
Brehm, a registered dietitian and professor at UCs
Several small studies had previously suggested that Mediterranean diets, with a large proportion of their fat content made up of monounsaturated fats such as olive oil, had beneficial effects on blood glucose and lipid levels in patients with diabetes. However, these results had been lost in the rush by dietitians and clinicians to reduce patients fat intake, and Mediterranean diets had not been tested in larger, longer-term studies of persons with diabetes.
The thinking has always been that high-fat diets were not healthy for anybody, says Brehm, but this shows that you can recommend a higher-fat diet, as long as it is healthy fat.
According to the study, reported first in the Oct. 28 e-publication of Diabetes Care, both diets were found to be equally beneficial: Both groups had similar weight loss over one year (approximately 4 kilograms, or 9 pounds) and had comparable improvement in body fat, waist circumference, diastolic blood pressure, HDL cholesterol, A1C and fasting glucose and insulin.
While a 4-kilogram weight loss is much less than what most patients want for cosmetic reasons, this is a clinically significant reduction, DAlessio says. Weight loss of this magnitude can improve blood pressure as well as lipid and glucose values, and also can reduce the number of medications people need to take.
The American Diabetes Association (ADA), which funded the UC study, reports that 23.6 million children and adults in the
Type 2 diabetes is a particularly important problem in the
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.